Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Eupraxia Pharmaceuticals (EPRX) Shares Outstanding (Entity) (2022 - 2025)

Updated

Eupraxia Pharmaceuticals' Shares Outstanding (Entity) came in at 39.96 million for Q4 2025, up 12.1% from 35.64 million a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Shares Outstanding (Entity) (2022 - 2025) Analysis & Trends

Going back to Q4 2022, Eupraxia Pharmaceuticals' Shares Outstanding (Entity) data covers 4 quarters.

  • Shares Outstanding (Entity) has increased in each of the last three years, with a three-year compound annual growth rate of 22.8% (FY2022 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 35.64 million in FY2024 (+30.6%), 27.28 million in FY2023 (+26.3%) and 21.59 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 940.75 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 540.90 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.24 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.70 Bn
10 Eupraxia Pharmaceuticals 304.87 Mn -174.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 39.96 Mn
Dec 31, 2024 35.64 Mn
Dec 31, 2023 27.28 Mn
Dec 31, 2022 21.59 Mn
API Access

Eupraxia Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=EPRX&period=max&api_key=YOUR_API_KEY